Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

PhRMA: 299 medicines under development for prevention and treatment of heart disease and stroke

An American dies of heart disease every 39 seconds, and African Americans suffer a higher death rate from heart disease and stroke than Americans overall. Partly as a result of having the highest prevalence of high blood pressure in the world, African Americans have a 1.5 times greater rate of heart disease death than other Americans and a 1.8 times greater rate of fatal stroke.

1 Feb 2011

Extensive, reversible changes in heart take place when exposed to low oxygen levels

From the highest mountaintop comes a new research report in the FASEB Journal that gets to the bottom of what happens to the hearts of people when exposed to low-levels of oxygen, such as those on Mount Everest or in the intensive care unit of a hospital.

1 Feb 2011

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

AVANIR Pharmaceuticals, Inc. today announced that NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) is now available by prescription in the United States. NUEDEXTA is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for pseudobulbar affect (PBA).

1 Feb 2011

ESC believes stress management programmes may reduce recurrent CVD events

Following the results of a study published in the Archives of Internal Medicine showing that cognitive behavioural therapy produces a 41% reduction in fatal and non-fatal first recurrent CVD events, the European Society of Cardiology believes stress management programmes should be made more widely available across Europe for patients with coronary artery disease.

29 Jan 2011

Apple Valley Medical Clinic inaugurates new Sleep Center to provide quality care

The Apple Valley Medical Clinic has opened a new Sleep Center, located at 15100 Galaxie Avenue in Apple Valley. The center, under the medical direction of Scott Benson, M.D., a family medicine physician with the Apple Valley Medical Clinic, offers preventive care, diagnosis and treatment of sleep disorders.

28 Jan 2011

Cardiac stem cell therapy can rebuild damaged heart in children

Visionaries in the field of cardiac therapeutics have long looked to the future when a damaged heart could be rebuilt or repaired by using one's own heart cells. A study published in the February issue of Circulation, a scientific journal of the American Heart Association, shows that heart stem cells from children with congenital heart disease were able to rebuild the damaged heart in the laboratory.

27 Jan 2011

Study finds surgery greatly reduces daytime sleepiness in sleep apnea patients

Patients with obstructive sleep apnea who undergo surgery to improve their breathing get a better night's sleep and therefore are less drowsy during the day, according to a new study from Henry Ford Hospital in Detroit.

27 Jan 2011

Phase III study affirms safety and efficacy of Cumberland's Caldolor for post-operative pain

Cumberland Pharmaceuticals Inc. today announced the publication of data affirming the safety and efficacy of Caldolor® (ibuprofen) Injection in treating post-operative pain in hospitalized patients. A Phase III study published in the peer-reviewed journal Pain Practice concluded that IV ibuprofen significantly reduced both morphine use and self-reported pain intensity in patients recovering from abdominal hysterectomy compared to morphine alone.

27 Jan 2011

NIH study helps explain survival rate discrepancy between cardiac arrest in public and home

Cardiac arrests that can be treated by electric stimulation, also known as shockable arrests, were found at a higher frequency in public settings than in the home, according to a National Institutes of Health-funded study appearing in the Jan. 27 issue of the New England Journal of Medicine.

27 Jan 2011

Study finds heart failure diagnosis four times higher in most economically disadvantaged communities

Heart failure diagnosis is four times higher in the most economically disadvantaged communities and twice as high among South Asians a new study at the University of Leicester has found.

25 Jan 2011

Middle-aged women could reduce risk of cardiovascular disease by lowering blood pressure

Large numbers of middle-aged women worldwide could reduce their risk of developing cardiovascular disease (stroke, heart attack and heart failure) and its complications by lowering their blood pressure, researchers report in Hypertension: Journal of the American Heart Association.

25 Jan 2011

American Heart Association: Cost of medical care for heart disease to raise in US by 2030

The cost to treat heart disease in the United States will triple by 2030, according to a policy statement published in Circulation: Journal of the American Heart Association.

25 Jan 2011

FDA approves IDE Supplement for third patient allotment in HeartWare Ventricular Assist System ADVANCE trial

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has approved an IDE Supplement that allows HeartWare to enroll a third allotment, of 94 additional patients, in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).

25 Jan 2011

NHLBI, HeartWare award $13.3M to study benefits of heart devices for heart failure

The University of Michigan Cardiovascular Center and the University of Pittsburgh have been awarded $13.3 million to explore the potential benefits of heart devices for the large and growing group of Americans with heart failure.

24 Jan 2011

AnC Bio Holdings invests $4 million in Bioheart

Bioheart, Inc. announced today that it has entered into an agreement with AnC Bio Holdings, Inc., a South Korean biomedical company, and one of its U.S. agents for a $4 million equity investment. Bioheart has designated proceeds from the investment to advance the current clinical evaluation of its cell therapies for treating heart failure and related cardiac diseases.

24 Jan 2011

First U.S. implant of RespiCardia System for treatment of sleep apnea

Cardiac Concepts, announced today the first U.S. clinical implant of the RespiCardia System at The Ohio State University Medical Center, Columbus, Ohio.

21 Jan 2011

Ultrasound device shows promise in breaking up pulmonary embolisms: Research

A tiny ultrasound device that helps dissolve blood clots is showing promise in breaking up potentially deadly pulmonary embolisms, blockages of blood vessels in the lungs that can occur after long plane rides, surgery and extended bed rest.

20 Jan 2011

Home blood pressure monitors can help people keep blood pressure in check

A recent research review has concluded that home blood pressure monitors can help people keep their blood pressure in check and possibly cut down on medication – as long as patients and their doctors put those home readings to good use. For years, Omron Healthcare, Inc. has reminded Americans how important home blood pressure monitoring is when it comes to reducing their risk of a heart attack or stroke, and truly wants people to take the news to heart in 2011.

19 Jan 2011

CJPS Medical Systems to launch VitalPoint Remote Patient Monitor in the U.K.

CJPS Medical Systems are launching into the U.K. market this week their VitalPoint® Remote Patient Monitor, a medical device capable of measuring patients' vital signs from home, allowing secure and direct communication with their caregiver, creating electronic medical records, and transmitting vital signs data.

19 Jan 2011

Geron commences enrollment in imetelstat Phase 2 clinical trial in essential thrombocythemia

Geron Corporation today announced enrollment of the first patient in a Phase 2 clinical trial to evaluate the activity of the company's telomerase inhibitor drug, imetelstat (GRN163L), in patients with essential thrombocythemia (ET).

19 Jan 2011

Heart Failure News and Research

Further Reading

PhRMA: 299 medicines under development for prevention and treatment of heart disease and stroke

Extensive, reversible changes in heart take place when exposed to low oxygen levels

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

ESC believes stress management programmes may reduce recurrent CVD events

Apple Valley Medical Clinic inaugurates new Sleep Center to provide quality care

Cardiac stem cell therapy can rebuild damaged heart in children

Study finds surgery greatly reduces daytime sleepiness in sleep apnea patients

Phase III study affirms safety and efficacy of Cumberland's Caldolor for post-operative pain

NIH study helps explain survival rate discrepancy between cardiac arrest in public and home

Study finds heart failure diagnosis four times higher in most economically disadvantaged communities

Middle-aged women could reduce risk of cardiovascular disease by lowering blood pressure

American Heart Association: Cost of medical care for heart disease to raise in US by 2030

FDA approves IDE Supplement for third patient allotment in HeartWare Ventricular Assist System ADVANCE trial

NHLBI, HeartWare award $13.3M to study benefits of heart devices for heart failure

AnC Bio Holdings invests $4 million in Bioheart

First U.S. implant of RespiCardia System for treatment of sleep apnea

Ultrasound device shows promise in breaking up pulmonary embolisms: Research

Home blood pressure monitors can help people keep blood pressure in check

CJPS Medical Systems to launch VitalPoint Remote Patient Monitor in the U.K.

Geron commences enrollment in imetelstat Phase 2 clinical trial in essential thrombocythemia

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News